EOS Imaging
EOS Imaging (EPA:EOSI) announced the launch of its new EOSedge next-generation imaging system in Europe, Canada and Australia.
EOSedge is a combination of X-ray detection, low-dose radiation and high-resolution imaging in the delivery of musculoskeletal imaging exams. It includes the company’s Flex Dose technology for modulating radiation dose to the patient’s body, along with high-resolution photon counting detection for optimal image quality.
The Paris-based company’s imaging system is also designed to improve patient comfort with an open cabin that includes a motorized, enlarged patient platform for easy access and quicker positioning. EOSedge offers local and full body, weight-bearing, low-dose biplanar exams of adult and pediatric patients.
EOSedge is awaiting FDA 510(k) approval.